Radiation boost may extend life in tough lung cancer
NCT ID NCT05068232
First seen Mar 17, 2026 · Last updated Apr 29, 2026 · Updated 4 times
Summary
This study is for people with extensive-stage small cell lung cancer that hasn't been treated yet. Researchers want to see if adding focused radiation to the standard combination of durvalumab and chemotherapy can help control the cancer longer. About 49 participants will receive the treatment and be followed for up to 48 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Chicago Medicine
RECRUITINGChicago, Illinois, 60637, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Wisconsin Carbone Cancer Center
ACTIVE_NOT_RECRUITINGMadison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.